Paris, France

Olivier Mir


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Olivier Mir: Innovator in Muscle Regeneration

Introduction

Olivier Mir is a notable inventor based in Paris, France. He has made significant contributions to the field of muscle regeneration, particularly through his innovative research and patents. With a total of 2 patents, Mir's work focuses on enhancing the self-renewal and differentiation of muscle stem cells.

Latest Patents

Olivier Mir's latest patents include a 5-hydroxytryptamine 1B receptor-stimulating agent. This invention is designed for use as a promoter of satellite cells' self-renewal and differentiation. The invention specifically addresses the replenishment of the in vivo muscle stem cells pool. It encompasses a composition that includes the receptor-stimulating agent, aimed at preventing and/or inhibiting the exhaustion of the satellite cells pool. Furthermore, the invention includes therapeutic and screening methods to enhance muscle regeneration.

Career Highlights

Throughout his career, Olivier Mir has worked with esteemed institutions such as Université Paris Descartes and Centre Hospitalier Sainte Anne Paris. His research has significantly impacted the understanding of muscle regeneration and the role of satellite cells in this process.

Collaborations

Olivier Mir has collaborated with notable colleagues, including Fabrice Bruno Chretien and Raphael Gaillard. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Olivier Mir stands out as an influential inventor in the realm of muscle regeneration. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and therapeutic applications in this vital field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…